Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
March 1st, 2022 |
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed) |
National Institutes of Health |
July 15th, 2021 |
Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 30th, 2021 |
Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
February 12th, 2023 |
Short-Term Mentored Research Career Enhancement Award to Promote Diversity (K18 No Independent Clinical Trials) |
National Institutes of Health |
July 30th, 2021 |
Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 30th, 2021 |
Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
July 1st, 2021 |
Preventive Health and Health Services Block Grant- 2021 |
Centers for Disease Control OSTLTS |
September 7th, 2021 |
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
August 24th, 2021 |
Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 28th, 2021 |
Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
May 26th, 2021 |
Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
June 1st, 2021 |
Improving Health of Americans with Intellectual and Developmental Disabilities Through Evidence-Based Health Promotion Programs |
Centers for Disease Control NCBDDD |
July 15th, 2021 |
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) |
National Institutes of Health |
June 1st, 2021 |
Improving Health of Americans with Mobility Limitations Through Evidence-Based Health Promotion Programs |
Centers for Disease Control NCBDDD |
March 5th, 2024 |
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) |
National Institutes of Health |
March 16th, 2024 |
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) |
National Institutes of Health |
January 29th, 2024 |
Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
October 13th, 2023 |
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
July 15th, 2021 |
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed) |
National Institutes of Health |
July 15th, 2021 |
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional) |
National Institutes of Health |
|
July 29th, 2021 |
Technologies to Advance Precision Medicine for Reproductive Health and Infertility (R43, R44 Clinical Trial Optional) |
National Institutes of Health |
March 5th, 2024 |
Research on Autism Spectrum Disorders (R01 Clinical Trial Optional) |
National Institutes of Health |
March 16th, 2024 |
Research on Autism Spectrum Disorders (R21 Clinical Trial Optional) |
National Institutes of Health |
March 16th, 2024 |
Research on Autism Spectrum Disorders (R03 Clinical Trial Optional) |
National Institutes of Health |
January 29th, 2024 |
NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
May 26th, 2021 |
Adolescent Girls and Young Women Reaching their Dreams Activity |
Zimbabwe USAID Harare |
August 4th, 2021 |
Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
May 28th, 2021 |
Strengthening animal health systems to enhance prevention, detection and response to emerging zoonotic diseases |
Centers for Disease Control NCEZID |
February 1st, 2023 |
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44) |
National Institutes of Health |
February 1st, 2023 |
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 30th, 2021 |
Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional) |
National Institutes of Health |
August 4th, 2021 |
Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional) |
National Institutes of Health |
April 23rd, 2021 |
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
National Institutes of Health |
February 1st, 2023 |
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
October 20th, 2021 |
Nutrition Obesity Research Centers (P30 Clinical Trial Optional) |
National Institutes of Health |
July 30th, 2021 |
Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional) |
National Institutes of Health |
July 30th, 2021 |
Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 29th, 2021 |
User-Based Design to Aid in Contraceptive Development by Small Business (R43 Clinical Trial Not Allowed) |
National Institutes of Health |
May 28th, 2021 |
Strengthening HIV Treatment, Laboratory Services, Medication Assisted Therapy, and Program Monitoring in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
June 21st, 2021 |
Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Existing Geographic Service Areas |
Health Resources and Services Administration |